ORM Act

This bill requires most employers to keep opioid overdose reversal drugs (like naloxone) on-site, based on workplace size and risk, and to train staff on recognizing overdoses and using the drugs. It sets a 1-year deadline for a temporary workplace rule and a 2-year deadline for a final rule from the Labor Secretary. The bill also expands federal grants to help businesses and communities access training and resources for these reversal drugs. These provisions directly affect employers and workers in settings where opioid overdoses could occur, aiming to improve on-site response capabilities.